Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) OZEMPIC semaglutide 0.25mg solution for injection pre-filled pen (Slovakia)
Section 19A approved medicine
(Approval lapsed) OZEMPIC semaglutide 0.25mg solution for injection pre-filled pen (Slovakia)
Section 19A approval holder
MedTas Pty Ltd ABN 72 644 270 860
Phone
1300 414 543
Approved until
Status
Expired
Medicines in short supply/unavailable
OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen - ARTG 308324
Indication(s)
OZEMPIC is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:
- as monotherapy when metformin is not tolerated or contraindicated.
- in addition to other medicinal products for the treatment of type 2 diabetes.
Images
